Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry
Pasquale Paolisso(CTO Andrea Alesini), Carmine Pizzi(Azienda USL di Bologna), Emanuele Gallinoro(Al-Azhar University), Gaetano Santulli(Albert Einstein College of Medicine), Arturo Cesaro(University of Campania "Luigi Vanvitelli"), Felice Gragnano(Ospedale Sant'Anna), Dobrin Vassilev, Alberto Foà(Azienda USL di Bologna), Giuseppe Esposito(Sapienza University of Rome), Raffaele Marfella(University of Campania "Luigi Vanvitelli"), Luca Bergamaschi(Ospedale G.B. Morgagni - L.Pierantoni), Ciro Mauro, Sara Amicone(University of Bologna), Angelo Sansonetti(University of Bologna), Nazzareno Galiè(Azienda USL di Bologna), Gianni Casella, Emanuele Barbato(CTO Andrea Alesini), Andrea Impellizzeri(I.R.C.C.S. Oasi Maria SS), Niya Mileva(Medical University of Sofia), Marta Belmonte(Onze Lieve Vrouwziekenhuis Hospital), Matteo Armillotta(University of Bologna), Nuccia Morici(Don Carlo Gnocchi Foundation), Paolo Calabrò(University of Campania "Luigi Vanvitelli"), Celestino Sardu(University of Campania "Luigi Vanvitelli"), Jacopo Oreglia(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda)
Cited by 77
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k
(untitled)
|European Heart Journal|2004|1k
Risk stratification and medical therapy of pulmonary arterial hypertension
|European Respiratory Journal|2018|834